TVARDI THERAPEUTICS, INC. Interest Receivable, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Interest Receivable, Current of $62.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:InterestReceivableCurrent · last filed 2025-03-11
- 2024-12-31: Interest Receivable, Current $62.00K.
- 2024-09-30: Interest Receivable, Current $99.00K.
- 2024-06-30: Interest Receivable, Current $119.00K.
- 2024-03-31: Interest Receivable, Current $160.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-12-31 | $62.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $99.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $119.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $160.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $139.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $232.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $420.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $495.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $489.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $451.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $468.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $438.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $455.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $318.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $305.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $346.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $311.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $365.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $401.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $847.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $971.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |